Advertisement

Acute Kidney Injury in Yellow Fever

  • Cassia Fernanda Estofolete
  • Rodrigo José Ramalho
  • Horácio José Ramalho
  • Mauricio Lacerda NogueiraEmail author
Chapter
  • 26 Downloads

Abstract

Yellow fever is an acute arbovirosis characterized by wide clinical spectrum, from asymptomatic to severe forms. The infection is transmitted by mosquitoes of the genus Aedes to humans. The disease usually occurs in two stages, and the yellow fever virus is viscerotropic, with the liver and kidney often affected in severe forms of disease. The renal involvement is multifactorial, including an effect of inflammation and viral replication.

Keywords

Yellow fever Acute kidney injury Arboviruses Hemorrhagic fever 

References

  1. 1.
    Vasconcelos P, Travassos da Rosa A, Pinheiro F, et al. Arboviruses pathogenic for man in Brazil. An overview of Arbovirology in Brazil and neighboring countries. Belem: Instituto Evandro Chagas; 1998. p. 72–99.Google Scholar
  2. 2.
    Rice CM, Lenches EM, Eddy SR, et al. Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science. 1985;229(4715):726–33.CrossRefGoogle Scholar
  3. 3.
    Barrett AD, Monath TP. Epidemiology and ecology of yellow fever virus. Adv Virus Res. 2003;61:291–315.CrossRefGoogle Scholar
  4. 4.
    Vasconcelos PF, Sperb AF, Monteiro HA, et al. Isolations of yellow fever virus from Haemagogus leucocelaenus in Rio Grande do Sul state, Brazil. Trans R Soc Trop Med Hyg. 2003;97(1):60–2.CrossRefGoogle Scholar
  5. 5.
    Brasil, MInistério da Saúde. Febre Amarela. Guia de Vigilância em Saúde. Volume unico. 2nd ed. Brasilia: Ministerio da Saude. Secretaria de Vigilância em Saude. Coordenação Geral de Desenvolvimento da Epidemiologia em Serviços; 2017. 705p.Google Scholar
  6. 6.
    Verma R, Khanna P, Chawla S. Yellow fever vaccine: an effective vaccine for travelers. Hum Vaccin Immunother. 2014;10(1):126–8.CrossRefGoogle Scholar
  7. 7.
    Franco O. A história da febre amarela no Brasil: Ministério da Saúde; 1969.Google Scholar
  8. 8.
    Romano AP, Costa ZG, Ramos DG, et al. Yellow fever outbreaks in unvaccinated populations, Brazil, 2008-2009. PLoS Negl Trop Dis. 2014;8(3):e2740.CrossRefGoogle Scholar
  9. 9.
    Goldani LZ. Yellow fever outbreak in Brazil, 2017. Braz J Infect Dis. 2017;21(2):123–4.CrossRefGoogle Scholar
  10. 10.
    Brès PL. A century of progress in combating yellow fever. Bull World Health Organ. 1986;64(6):775–86.PubMedPubMedCentralGoogle Scholar
  11. 11.
    Monath TP. Yellow fever: an update. Lancet Infect Dis. 2001;1(1):11–20.CrossRefGoogle Scholar
  12. 12.
    Monath TP, Barrett AD. Pathogenesis and pathophysiology of yellow fever. Adv Virus Res. 2003;60:343–95.CrossRefGoogle Scholar
  13. 13.
    Vasconcelos PF. Yellow fever. Rev Soc Bras Med Trop. 2003;36(2):275–93.CrossRefGoogle Scholar
  14. 14.
    Monath TP, Vasconcelos PF. Yellow fever. J Clin Virol. 2015;64:160–73.CrossRefGoogle Scholar
  15. 15.
    Houghton-Triviño N, Montaña D, Castellanos J. Dengue-yellow fever sera cross-reactivity; challenges for diagnosis. Rev Salud Publica (Bogota). 2008;10(2):299–307.CrossRefGoogle Scholar
  16. 16.
    Vasconcelos PF, Costa ZG, Travassos Da Rosa ES, et al. Epidemic of jungle yellow fever in Brazil, 2000: implications of climatic alterations in disease spread. J Med Virol. 2001;65(3):598–604.CrossRefGoogle Scholar
  17. 17.
    Lima EQ, Nogueira ML. Viral hemorrhagic fever-induced acute kidney injury. Semin Nephrol. 2008;28(4):409–15.CrossRefGoogle Scholar
  18. 18.
    Burdmann EA, Jha V. Acute kidney injury due to tropical infectious diseases and animal venoms: a tale of 2 continents. Kidney Int. 2017;91(5):1033–46.CrossRefGoogle Scholar
  19. 19.
    Gershy-Damet GM. Ultrastructural changes caused by yellow fever virus at the level of the kidneys in newborn mice. Arch Inst Pasteur Tunis. 1984;61(1):97–106.PubMedGoogle Scholar
  20. 20.
    Engelmann F, Josset L, Girke T, et al. Pathophysiologic and transcriptomic analyses of viscerotropic yellow fever in a rhesus macaque model. PLoS Negl Trop Dis. 2014;8(11):e3295.CrossRefGoogle Scholar
  21. 21.
    Staples JE, Gershman M, Fischer M, (CDC) CfDCaP. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2010;59(RR-7):1–27.PubMedGoogle Scholar
  22. 22.
    World Health Organization. Vaccines and vaccination against yellow fever: WHO Position Paper, June 2013--recommendations. Vaccine. 2015;33(1):76–7.CrossRefGoogle Scholar
  23. 23.
    Sociedade Brasileira de Nefrologia. Recomendações do manejo de Febre amarela em paciente critico de autoria do grupo de IRA da USP: Sociedade Brasileira de Nefrologia; 2018. Available from https://sbn.org.br/blog/recomendacoes-do-manejo-de-febre-amarela-em-paciente-critico.

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Cassia Fernanda Estofolete
    • 1
  • Rodrigo José Ramalho
    • 1
  • Horácio José Ramalho
    • 2
  • Mauricio Lacerda Nogueira
    • 3
    Email author
  1. 1.Division of Infectious DiseasesHospital de Base de Sao Jose do Rio Preto, School of Medicine of Sao Jose do Rio PretoSao Jose do Rio PretoBrazil
  2. 2.Division of NephrologySchool of Medicine of Sao Jose do Rio PretoSao Jose do Rio PretoBrazil
  3. 3.Department of Parasitic and Infectious DiseasesSchool of Medicine of Sao Jose do Rio PretoSao Jose do Rio PretoBrazil

Personalised recommendations